EDGAR Filing Documents for 0001104659-21-128952

Form 424B4 - Prospectus [Rule 424(b)(4)]:

SEC Accession No. 0001104659-21-128952

Filing Date

2021-10-22

Accepted

2021-10-22 16:02:13

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B4	tm2115750-18_424b4.htm	424B4	4125382
2	GRAPHIC	lg_xilio-4c.jpg	GRAPHIC	87057
3	GRAPHIC	tm2115750d1-lc_highdosebw.jpg	GRAPHIC	59535
4	GRAPHIC	tm2115750d1-lc_pembro4c.jpg	GRAPHIC	118788
5	GRAPHIC	tm2115750d1-lc_proteoly4c.jpg	GRAPHIC	84879
6	GRAPHIC	tm2115750d1-lc_singledose4c.jpg	GRAPHIC	82408
7	GRAPHIC	tm2115750d1-ph_receptor4c.jpg	GRAPHIC	105641
8	GRAPHIC	tm2115750d12-bc_pipeline4c.jpg	GRAPHIC	1359324
9	GRAPHIC	tm2115750d12-lc_potent4c.jpg	GRAPHIC	137524
10	GRAPHIC	tm2115750d5-bc_masked4c.jpg	GRAPHIC	69017
11	GRAPHIC	tm2115750d5-fc_101trial4c.jpg	GRAPHIC	56084
12	GRAPHIC	tm2115750d5-fc_202trial4c.jpg	GRAPHIC	70746
13	GRAPHIC	tm2115750d5-fc_antibody4c.jpg	GRAPHIC	203189
14	GRAPHIC	tm2115750d5-fc_cytokine4c.jpg	GRAPHIC	206005
15	GRAPHIC	tm2115750d5-lc_affect4clr.jpg	GRAPHIC	91391
16	GRAPHIC	tm2115750d5-lc_decouples4c.jpg	GRAPHIC	104873
17	GRAPHIC	tm2115750d5-lc_demonstrat4c.jpg	GRAPHIC	104998
18	GRAPHIC	tm2115750d5-lc_tolerated4c.jpg	GRAPHIC	50003
19	GRAPHIC	tm2115750d5-lc_xtx2024clr.jpg	GRAPHIC	39924
20	GRAPHIC	tm2115750d5-ph_platform4c.jpg	GRAPHIC	136815
21	GRAPHIC	tm2115750d9-bc_pstat4c.jpg	GRAPHIC	115933
22	GRAPHIC	tm2115750d9-bc_sign4c.jpg	GRAPHIC	131946
23	GRAPHIC	tm2115750d9-lc_peri24clr.jpg	GRAPHIC	89193
24	GRAPHIC	tm2115750d9-lc_posttr4c.jpg	GRAPHIC	98009
25	GRAPHIC	tm2115750d9-lc_splenom4c.jpg	GRAPHIC	77812
26	GRAPHIC	tm2115750d9-lc_toxic4clr.jpg	GRAPHIC	117874
27	GRAPHIC	tm2115750d9-lc_toxicity4c.jpg	GRAPHIC	119382
28	GRAPHIC	tm2115750d9-lc_well4c.jpg	GRAPHIC	159195
	Complete submission text file	0001104659-21-128952.txt		9708055

Mailing Address 828 WINTER STREET WALTHAM MA 02451

Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027

Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)